Q3 2024
|
29 |
186,812 |
INSM, TARS, MRUS, CGON
|
13F-HR
|
11/14/2024 |
000095012324011470 |
Q2 2024
|
25 |
167,861 |
SLNO, SRPT, GERN, MRUS
|
13F-HR
|
8/14/2024 |
000095012324008408 |
Q1 2024
|
22 |
179,888 |
BPMC, SLNO, CG ONCOLOGY INC, XENE
|
13F-HR
|
5/15/2024 |
000095012324005227 |
Q4 2023
|
22 |
167,825 |
JSPR, ARGX, SLNO, CBAY
|
13F-HR
|
2/14/2024 |
000095012324002153 |
Q3 2023
|
19 |
85,197 |
MLTX, XENE, ITCI, AXSM
|
13F-HR
|
11/14/2023 |
000095012323010736 |
Q2 2023
|
17 |
82,561 |
RETA, I9SA.HA, XENE, CYTK
|
13F-HR
|
8/14/2023 |
000095012323008083 |
Q1 2023
|
18 |
76,289 |
I9SA.HA, XENE, BLU.TO, CYTK
|
13F-HR
|
5/15/2023 |
000095012323004992 |
Q4 2022
|
30 |
102,791 |
RARE, AADI, ACAD, MRSN
|
13F-HR
|
2/14/2023 |
000095012323002336 |
Q3 2022
|
39 |
151,465 |
SGEN, RARE, SNY, KPTI
|
13F-HR
|
11/14/2022 |
000095012322011716 |
Q2 2022
|
22 |
109,726 |
ARGX, MDVL, COGT, LNTH
|
13F-HR
|
8/15/2022 |
000095012322009121 |
Q1 2022
|
21 |
134,909 |
LNTH, ISEE, GH, ARVN
|
13F-HR
|
5/16/2022 |
000095012322005946 |
Q4 2021
|
30 |
286,118 |
NTRA, ARVN, RGEN, ISO
|
13F-HR
|
2/14/2022 |
000095012322002404 |
Q3 2021
|
31 |
340,097 |
NTRA, SPDR SER TR puts, RGEN, ARVN
|
13F-HR
|
11/15/2021 |
000095012321015123 |
Q2 2021
|
29 |
402,525 |
MDVL, SPDR SER TR puts, NTRA, FATE
|
13F-HR
|
8/16/2021 |
000095012321011101 |
Q1 2021
|
32 |
521,595 |
SPDR SER TR puts, AVIR, MDVL, CERE
|
13F-HR
|
5/17/2021 |
000095012321006746 |
Q4 2020
|
30 |
583,531 |
SPDR SER TR puts, MDVL, AVIR, SAREPTA THERAPEUTICS INC calls
|
13F-HR
|
2/16/2021 |
000095012321002363 |